UATG LOGO Jan. 16.jpg
UAT Group Strategic Partner NextCast Receives Patent Approval
October 18, 2021 08:00 ET | Umbra Applied Technologies Group, Inc.
Tampa, FL, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc (OTC Pink: UATG) (“UAT Group”) announced today that strategic partner Next Casting Technologies has received its...
SPOM LOGO.png
SPO Global Inc. (OTC Pink: SPOM) Provides a Shareholder Update
September 30, 2021 09:00 ET | SPO Global Inc.
Shandong, China, Sept. 30, 2021 (GLOBE NEWSWIRE) -- CEO Lu Fengyu of SPO Global Inc. (OTC Pink: SPOM) met Mr. Luo (Chairman of China Science and Technology Financial Holdings Fund Company), Mr. Gao...
UATG LOGO Jan. 16.jpg
UAT Group Inc. Acquires Additional 6% of Next Casting Technologies
August 26, 2021 08:00 ET | Umbra Applied Technologies Group, Inc.
Tampa, FL, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc. (OTC Pink: UATG) announced today that it has purchased an additional 6% of the Austin, Texas based medical company...
LactigaLogo.png
Lactiga Continues to Build a Substantial Global Biologics Patent Portfolio
July 20, 2021 09:00 ET | Lactiga, Inc
PRINCETON, N.J., July 20, 2021 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), a biotherapeutics company advancing anti-infective biologics to prevent mucosal infections in immunodeficient patients,...
AMR Logo.png
Global Prime Editing and CRISPR Market is Expected to Reach $23.49 Billion by 2030: Says AMR
July 13, 2021 08:54 ET | Allied Market Research
Portland, OR, July 13, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Prime Editing And CRISPR Market was estimated at $2.69 billion in 2020 and is...
Xphyto logo.jpg
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic Therapies
June 15, 2021 11:10 ET | XPhyto Therapeutics Corp.
VANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on...
gmi logo.jpg
Shape Memory Polymer Market projected to surpass $1 billion by 2027, Says Global Market Insights Inc.
April 08, 2021 06:00 ET | Global Market Insights, Inc
Selbyville, Delaware, April 08, 2021 (GLOBE NEWSWIRE) -- Based on Global Market Insights Inc., report, the Shape Memory Polymer Market was estimated at $392.4 million in 2020 and is slated to exceed...
Xphyto logo.jpg
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Recent European Approval of 25-Minute COVID-19 PCR Test
March 29, 2021 08:30 ET | XPhyto Therapeutics Corp.
VANCOUVER, British Columbia, March 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on...
Milestone Scientific LOGO.jpg
Milestone Scientific to Present at the Q1 Virtual Investor Summit
March 12, 2021 07:00 ET | Milestone Scientific Inc.
ROSELAND, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provides virtually...
AXOVIA Transparent Background_Color.png
Renowned Geneticist Philip Beales Launches Axovia Therapeutics to Develop Transformative Medicines for Ciliopathies
February 25, 2021 07:00 ET | Axovia Therapeutics
Axovia is focused on developing transformative gene therapies for cilia disorders, starting with Bardet-Biedl SyndromeAxovia is a majority-owned subsidiary of Jaguar Gene Therapy, which is backed by...